CAV1 and non-small cell lung carcinoma: As shown in Supplementary Table S4, in the age group <60 years old, for the rs3779514 in CAV1, the study subjects carrying the CT + TT genotype showed a lower likelihood of developing NSCLC compared to the CC genotype, with a 54.7% lower risk of developing NSCLC (OR = 0.453, 95% CI = 0.238-0.863, p = 0.016).